IOL Chemicals and Pharmaceuticals Ltd. up by 14.16% | Espresso

EspressoLogy

Espresso Shot of the Day - IOL Chemicals and Pharmaceuticals Ltd. up by 14.16%

December 21, 2022
Espresso Shot of the Day - IOL Chemicals and Pharmaceuticals Ltd. up by 14.16%

IOL CHEMICALS & PHARMACEUTICALS LTD 399.45 (+14.16%) BSE INE485C01011| 21st December 2022

https://www.myespresso.com//images/Esd-%20IOL%20CHEMICALS%20&%20PHARMACEUTICALS%20LTD.-202212211859578888983.PNG

IOL Chemicals and Pharmaceuticals Limited is an innovation-driven Bulk Drug, Intermediates, and Specialty Chemicals Company, built on a prolific history of progress and expansion over three decades. They are strategically expanding our product portfolio with a pipeline of new products that will form a strong foundation for future growth. They are an API based pharmaceutical company, with substantive manufacturing capacities that lend them economies of scale and cost supremacy. They also have extensive expertise in specialty chemicals, which provides us a foundation for diversified growth opportunities and strengthens their business model.


Recent Drivers

  • On August 10th,2022 Net Sales at Rs 565.01 crore in June 2022 up 8.97% from Rs. 518.51 crore in June 2021.
  • On Nov 16th,2022 IOL Chemicals and Pharmaceuticals said, "the Board of Directors in its meeting held on 14th November 2022 has also approved the formation of a wholly owned subsidiary of the Company in United Kingdom (UK) which gives better business growth opportunities and promoting business globally."
  • On November 7th , 2022 IOL Chemicals and Pharmaceuticals said it has received certificate of suitability from EDQM to supply Pantoprazole Sodium Sesquihydrate API in European markets. The European Directorate for the Quality of Medicines & HealthCare (EDQM) is a mandatory certification for distribution of any API/ pharma products in Europe.
  • On July 5th,2022, t Rating on Long-term facilities worth Rs140 crore has been reaffirmed at A+, with a Stable outlook. Company’s short-term facilities worth Rs410 crore (enhanced from RS210 crore) have been assigned (reaffirmed) a A1+ rating.
  • On April 25th,2022, IOL Chemicals & Pharmaceuticals Ltd has informed that the Company has commenced the commercial production of 'Paracetamol' with installed capacity of 1800 MTPA along with backward integration of Para Amino Phenol (PAP) with effect from April 22, 2022.
(Sources: BSE, Money control, Business Standard, Economic Times) 

Technical Force*

  • S&P BSE Small cap month till date loss by 1.93%.
  • 3 months avg. NSE volume: 155,086
  • Traded on new 52 Week High Value of 536.70
  • Quantity traded: 3,32,215 | Deliverable quantity 68,006 (20.47)
  • Stock price jumped by more than 70% from a one-year low level: 295.10 (March 8th, 2022)
  • Daily RSI (14) is above overbought territory today.
  • 52-week-high: 536.70 | 52-week-low: 295.10


Key Pivot (Yearly)

R4

R3

R2

R1

PP/FIB PP

S1

S2

S3

Pivot Point

-

1031.77

898.43

690.92

557.58

350.07

216.73

9.22

Fibonacci Pivot

898.43

768.23

687.79

653.98

557.58

479.19

427.38

346.94


Today’s Close

399.45

SMA

BSE

10 DAY

343.04

20 DAY

351.28

50 DAY

358.59

200 DAY

370.14


Some Key Ratios (Source: BSE)

Market Cap:  914.55 Crores

PE: 19.81

OPM%: -

ROE%: 8.22

Promoters holding%: 43.69

Prev. Close:  349.90


https://www.myespresso.com/images/espresso_shot_blog_credit_image-202212011811370680578.jpg

The scope and usability of this information/data is time-sensitive and market-based, and as such the same may become outdated for the investment decisions of clients, for which Espresso Financial Services Pvt. Ltd bears no responsibility. References to securities do not constitute a recommendation to buy, sell or hold such securities. The user assumes the entire risk of any use made of this information. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document and should consult his own advisors to determine the merits and risks of such an investment. Espresso Financial Services Pvt. Limited is under no obligation to update the information in this document from time-to-time.

                                                                                                      

Chandresh Khona
by Chandresh Khona

Product Offerings Head

A teacher, writer, travel buff and now Espresso's Product Offerings Head. Ten years here has allowed me to lead the digital team at Sharekhan. My true passion lies in stock market charts.